Hypertrophic cardiomyopathy: open trials in China

19 open trials have a site in China. Registry data; only the trial team decides who can take part.

NCT07361289
A Study to Assess the Real-World Effectiveness of Mavacamten in Adult Patients With Obstructive Hypertrophic Cardiomyopathy in China
Research · Bristol-Myers Squibb
Peking University First Affiliated Hospital, Beijing · Peking Union Medical College Hospital, Beijing · Beijing · The Second Hospital of Jilin University, Changchun · West China Hospital of Sichuan University, Chengdu · The First Affiliated Hospital of Dalian Medical University, Dalian · The First Affiliated Hospital, Sun Yat-sen University, Guangzhou · The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou · Harbin · The Second Afilliated Hospital of Hebei Medical University, Jiazhuang · Jinan · Zhongshan Hospital,Fudan University, Shanghai · Suzhou Municipal Hospital, Suzhou · Xi'an · Zhengzhou
Registry updated 2026-11-02
NCT07846059
Evaluation of Mavacamten-Based Practice in Chinese Adults With Obstructive Hypertrophic Cardiomyopathy
Research · Bristol-Myers Squibb
Fudan University Zhongshan Hospital, Shanghai
Registry updated 2026-09-29
NCT06775665
A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population
Research · Second Affiliated Hospital, Zhejiang University, School of Medicine
Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou · 2nd Affiliated Hospital, School of Medicine, Zhejiang University, China, Hangzhou
Registry updated 2026-09-15
NCT07103655
The Therapeutic Value of Mavacamten in Hypertrophic Cardiomyopathy With Mid-to-Apical Left Ventricular Obstruction
Trial Treatment · Phase 4 · Second Affiliated Hospital, Zhejiang University, School of Medicine
Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Registry updated 2026-09-15
NCT07815301
Gradual Tapering or Discontinuation of Beta-Blockers After Stabilization With Mavacamten Therapy
Trial Treatment · First Affiliated Hospital of Wenzhou Medical University
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Registry updated 2026-09-11
NCT07638033
A Real-world HCM-cohort Trial
Research · Xijing Hospital
The First Affiliated Hospital of the Air Force Medical University, Xi'an
Registry updated 2026-06-10
NCT07367724
Ademetionine in Obstructive Hypertrophic Cardiomyopathy
Trial Treatment · Phase 2 · China National Center for Cardiovascular Diseases
Fuwai Hospital, Beijing · Zhongshan Hospital, Shanghai Medical College of Fudan University, Shanghai · The First Affiliated Hospital of Xinjiang Medical University, Xinjiang
Registry updated 2026-03-20
NCT07483125
Valsalva SBP Drop and LVOT Obstruction
Research · Shanghai Zhongshan Hospital
Zhongshan Hospital, Shanghai
Registry updated 2026-03-19
NCT07464132
Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases
Trial Treatment · Phase 1/2 · Peking Union Medical College Hospital
Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing
Registry updated 2026-03-11
NCT07354646
The Application of T1 Mapping in Real-World
Research · Chinese Academy of Medical Sciences, Fuwai Hospital
Fuwai Hospital Chinese Academy of Medical Sciences, Beijing
Registry updated 2026-01-21
NCT07294495
Effect of Henagliflozin on Myocardial Fibrosis in Non-Obstructive HCM: A Randomized, Double-Blind, Placebo-Controlled Trial Using 68Ga/18F-FAPI PET/CMR
Trial Treatment · Shanghai East Hospital
Shanghai East Hospital, Shanghai
Registry updated 2025-12-19
NCT07006493
REFINE-HCM: Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy
Trial Treatment · SuZhou Sinus Medical Technologies Co.,Ltd
Capital Medical University Affiliated Beijing Anzhen Hospital, Beijing · Sir Run Run Shaw Hospital, Hangzhou
Registry updated 2025-12-15
NCT07263204
AI-Enabled Diagnosis and Prognosis of Hypertrophic Cardiomyopathy
Research · Second Affiliated Hospital, Zhejiang University, School of Medicine
Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Registry updated 2025-12-04
NCT07021963
A Clinical Study to Evaluate the Long-term Safety of HRS-1893 in Hypertrophic Cardiomyopathy
Trial Treatment · Phase 2 · Shandong Suncadia Medicine Co., Ltd.
Fuwai Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing
Registry updated 2025-09-10
NCT06794710
Early Identification and Treatment of Rare Cardiomyopathy Cohorts
Trial Treatment · RenJi Hospital
RenJi Hospital, Shanghai
Registry updated 2025-01-27
NCT06683872
Evaluation of Clinical Efficacy and Prognosis in Patients With Hypertrophic Obstructive Cardiomyopathy Through Hemodynamic Modeling Reconstructed by CT
Research · Zhejiang Provincial People's Hospital
Zhejiang Province People's Hospital, Hangzhou
Registry updated 2024-11-12
NCT05610215
Concomitant Hybrid Versus Catheter Ablation for Atrial Fibrillation With Hypertrophic Cardiomyopathy
Trial Treatment · China National Center for Cardiovascular Diseases
Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing
Registry updated 2024-08-30
NCT03821051
China Structural Ventricular Arrhythmias Registry
Research · China National Center for Cardiovascular Diseases
China National Center for Cardiovascular Diseases, Beijing
Registry updated 2019-01-29
NCT02696135
The Chinese Hypertrophic Cardiomyopathy Study(CHCS)
Research · China National Center for Cardiovascular Diseases
Fuwai Hospital, Beijing
Registry updated 2018-03-27

All Hypertrophic cardiomyopathy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error